4//SEC Filing
Anicetti Vincent R 4
Accession 0001567619-21-005917
CIK 0001512762other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:24 PM ET
Size
10.7 KB
Accession
0001567619-21-005917
Insider Transaction Report
Form 4
Anicetti Vincent R
Chief, Quality & Compliance
Transactions
- Sale
Common Stock
2021-03-05$15.46/sh−20,312$314,095→ 59,739 total - Sale
Common Stock
2021-03-05$15.46/sh−6,337$97,970→ 53,402 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-05−20,312→ 4,688 totalExercise: $9.30Exp: 2027-11-15→ Common Stock (20,312 underlying) - Exercise/Conversion
Common Stock
2021-03-05$9.30/sh+20,312$188,902→ 80,051 total
Footnotes (3)
- [F1]Includes 52,083 restricted stock units.
- [F2]The transaction was executed in multiple trades in prices ranging from $15.45 to $15.54, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from November 15, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Coherus BioSciences, Inc.
CIK 0001512762
Entity typeother
Related Parties
1- filerCIK 0001733375
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 4:24 PM ET
- Size
- 10.7 KB